Equasens Société anonyme Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Equasens Société anonyme ha aumentado sus beneficios a una tasa media anual de 15.5%, mientras que los beneficios de la industria de Healthcare Services han experimentado un crecimiento de 2.2% anual. Los ingresos han ido creciendo a una tasa media de 9.6% al año. La rentabilidad financiera de Equasens Société anonyme es de 25%, y sus márgenes netos son de 21.7%.
Información clave
15.5%
Tasa de crecimiento de los beneficios
15.4%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare Services | 21.0% |
Tasa de crecimiento de los ingresos | 9.6% |
Rentabilidad financiera | 25.0% |
Margen neto | 21.7% |
Próxima actualización de resultados | 27 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?
Dec 01Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Equasens Société anonyme. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 23 | 223 | 48 | 0 | 0 |
31 Mar 23 | 219 | 47 | 0 | 0 |
31 Dec 22 | 214 | 46 | 0 | 0 |
30 Jun 22 | 203 | 42 | 0 | 0 |
31 Mar 22 | 198 | 41 | 0 | 0 |
31 Dec 21 | 193 | 39 | 0 | 0 |
30 Sep 21 | 190 | 37 | 0 | 0 |
30 Jun 21 | 188 | 35 | 0 | 0 |
31 Mar 21 | 180 | 33 | 0 | 0 |
31 Dec 20 | 172 | 31 | 0 | 0 |
30 Sep 20 | 166 | 29 | 0 | 0 |
30 Jun 20 | 160 | 27 | 0 | 0 |
31 Mar 20 | 159 | 27 | 0 | 0 |
31 Dec 19 | 159 | 27 | 0 | 0 |
30 Sep 19 | 156 | 27 | 0 | 0 |
30 Jun 19 | 153 | 26 | 0 | 0 |
31 Mar 19 | 151 | 26 | 0 | 0 |
31 Dec 18 | 148 | 25 | 0 | 0 |
30 Sep 18 | 144 | 25 | 0 | 0 |
30 Jun 18 | 139 | 24 | 0 | 0 |
31 Mar 18 | 134 | 24 | 0 | 0 |
31 Dec 17 | 130 | 23 | 0 | 0 |
30 Sep 17 | 129 | 22 | 0 | 0 |
30 Jun 17 | 128 | 21 | 0 | 0 |
31 Mar 17 | 128 | 21 | 0 | 0 |
31 Dec 16 | 128 | 21 | 0 | 0 |
30 Sep 16 | 125 | 20 | 0 | 0 |
30 Jun 16 | 121 | 20 | 0 | 0 |
31 Mar 16 | 117 | 19 | 0 | 0 |
31 Dec 15 | 113 | 19 | 0 | 0 |
30 Sep 15 | 113 | 18 | 0 | 0 |
30 Jun 15 | 112 | 18 | 0 | 0 |
31 Mar 15 | 113 | 17 | 0 | 0 |
31 Dec 14 | 115 | 17 | 0 | 0 |
30 Sep 14 | 114 | 17 | 0 | 0 |
30 Jun 14 | 113 | 16 | 0 | 0 |
31 Mar 14 | 113 | 16 | 0 | 0 |
31 Dec 13 | 113 | 16 | 0 | 0 |
30 Sep 13 | 113 | 15 | 0 | 0 |
30 Jun 13 | 113 | 15 | 0 | 0 |
Ingresos de calidad: EQS tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (21.7%) de EQS son superiores a los del año pasado (20.8%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de EQS han crecido un 15.5% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de EQS en el último año (14.8%) está por debajo de su media de 5 años (15.5% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de EQS en el último año (14.8%) superó al de la industria Healthcare Services 11.7%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera (25%) de EQS se considera alta.